Blue Trust Inc’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Blue Trust Inc’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-42	Closed	-$5K	–	2833
2023 Q4	$5K	Buy	+42	New	+$4.88K	﹤0.01%	1885
2023 Q3	–	Sell	-10	Closed	-$1K	–	2368
2023 Q2	$1K	Sell	10 -100	-91%	-$10.6K	﹤0.01%	1979
2023 Q1	$13K	Buy	110 +82	+293%	+$9.06K	﹤0.01%	1530
2022 Q4	$2K	Buy	28 +14	+100%	+$1.16K	﹤0.01%	1992
2022 Q3	$1K	Hold	14	–	–	﹤0.01%	2054
2022 Q2	$1K	Buy	+14	New	+$1.33K	﹤0.01%	1872

Other funds holding HZNP

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Blue Trust Inc's HZNP Position: Q1 2024 in Review

Blue Trust Inc sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2024, closing a stake of 42 shares — an estimated $5K sold.

Blue Trust Inc first reported a position in HZNP in Q2 2022 and held it in 6 quarters. The position peaked at $13K in Q1 2023. 1 fund tracked by Wall St. Rank holds HZNP as of Q1 2024.

Blue Trust Inc reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2024 after selling out during the quarter.
Blue Trust Inc sold 42 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2024, an estimated $5K.
Blue Trust Inc first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022 and held it in 6 quarters.
Blue Trust Inc's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $13K in Q1 2023.
1 fund tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2024.

Based on Blue Trust Inc's 13F filing for Q1 2024, filed 1 May 2024.